Ali Roghanian | Associate Prof in Cancer Immunotherapy
University of Southampton

Ali Roghanian is an Associate Professor in Cancer Immunotherapy at the University of Southampton, UK. With a background in basic and translational immunology and a focus on cancer research, Ali is dedicated to advancing the field of biologics and immunotherapy. His research interests lie in understanding the immune system's response to cancer and developing novel biologics-based treatments to target and eliminate cancer cells (e.g., via targeting inhibitory human FcγRIIB [CD32B] and LILRBs). Ali's work aims to improve patient outcomes and quality of life through innovative approaches in cancer immunotherapy. Ali has a strong publication record and is committed to advancing the field through his work and by mentoring future scientists. Catch Ali Roghanian at the Festival of Biologics Basel 2025, where he will share his insights and expertise in this cutting-edge field.